MidWestOne Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-612
| Closed | -$249K | – | 302 |
|
|
2023
Q4 | $249K | Sell |
612
-1,040
| -63% | -$423K | 0.05% | 257 |
|
|
2023
Q3 | $574K | Sell |
1,652
-544
| -25% | -$189K | 0.13% | 177 |
|
|
2023
Q2 | $773K | Buy |
2,196
+184
| +9% | +$64.8K | 0.17% | 159 |
|
|
2023
Q1 | $634K | Sell |
2,012
-2,238
| -53% | -$705K | 0.14% | 166 |
|
|
2022
Q4 | $1.23M | Sell |
4,250
-484
| -10% | -$140K | 0.27% | 82 |
|
|
2022
Q3 | $1.37M | Sell |
4,734
-364
| -7% | -$105K | 0.35% | 59 |
|
|
2022
Q2 | $1.44M | Sell |
5,098
-112
| -2% | -$31.6K | 0.36% | 59 |
|
|
2022
Q1 | $1.36M | Sell |
5,210
-1,617
| -24% | -$422K | 0.29% | 80 |
|
|
2021
Q4 | $1.5M | Buy |
6,827
+4,082
| +149% | +$896K | 0.31% | 75 |
|
|
2021
Q3 | $498K | Buy |
+2,745
| New | +$498K | 0.12% | 161 |
|